Year |
Citation |
Score |
2021 |
Biering SB, Van Dis E, Wehri E, Yamashiro LH, Nguyenla X, Dugast-Darzacq C, Graham TGW, Stroumza JR, Golovkine GR, Roberts AW, Fines DM, Spradlin JN, Ward CC, Bajaj T, Dovala D, et al. Screening a Library of FDA-Approved and Bioactive Compounds for Antiviral Activity against SARS-CoV-2. Acs Infectious Diseases. PMID 34129317 DOI: 10.1021/acsinfecdis.1c00017 |
0.505 |
|
2017 |
Bateman LA, Nguyen TB, Roberts AM, Miyamoto DK, Ku WM, Huffman TR, Petri Y, Heslin MJ, Contreras CM, Skibola CF, Olzmann JA, Nomura DK. Chemoproteomics-enabled covalent ligand screen reveals a cysteine hotspot in reticulon 4 that impairs ER morphology and cancer pathogenicity. Chemical Communications (Cambridge, England). PMID 28352901 DOI: 10.1039/C7Cc01480E |
0.678 |
|
2017 |
Roberts AM, Miyamoto DK, Huffman TR, Bateman LA, Ives AN, Heslin MJ, Akopian D, Contreras CM, Rape M, Skibola CF, Nomura DK. Chemoproteomic Screening of Covalent Ligands Reveals UBA5 as a Novel Pancreatic Cancer Target. Acs Chemical Biology. PMID 28186401 DOI: 10.1021/Acschembio.7B00020 |
0.7 |
|
2017 |
Kulkarni RA, Worth AJ, Zengeya TT, Shrimp JH, Garlick JM, Roberts AM, Montgomery DC, Sourbier C, Gibbs BK, Mesaros C, Tsai YC, Das S, Chan KC, Zhou M, Andresson T, et al. Discovering Targets of Non-enzymatic Acylation by Thioester Reactivity Profiling. Cell Chemical Biology. PMID 28163016 DOI: 10.1016/J.Chembiol.2017.01.002 |
0.367 |
|
2016 |
Roberts AM, Ward CC, Nomura DK. Activity-based protein profiling for mapping and pharmacologically interrogating proteome-wide ligandable hotspots. Current Opinion in Biotechnology. 43: 25-33. PMID 27568596 DOI: 10.1016/J.Copbio.2016.08.003 |
0.658 |
|
2016 |
Sorum AW, Shrimp JH, Roberts AM, Montgomery DC, Tiwari NK, Lal-Nag M, Simeonov A, Jadhav A, Meier JL. Microfluidic Mobility Shift Profiling of Lysine Acetyltransferases Enables Screening and Mechanistic Analysis of Cellular Acetylation Inhibitors. Acs Chemical Biology. 11: 734-41. PMID 26428393 DOI: 10.1021/Acschembio.5B00709 |
0.391 |
|
Show low-probability matches. |